Last update 08 Mar 2025
Shandong Anhong Pharmaceutical Co., Ltd.

Shandong Anhong Pharmaceutical Co., Ltd.

Private Company | Subsidiary Company|
2009|
Shandong Sheng, China
|
www.qilulinyi-antibiotics.com

Overview

Tags

Skin and Musculoskeletal Diseases
Infectious Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
SQLE(Squalene monooxygenase)1

Related

1
Drugs associated with Shandong Anhong Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride
Target
SQLE
Mechanism
SQLE inhibitors [+1]
Active Org.
Novartis Pharmaceuticals Australia Pty Ltd. [+8]
Originator Org.
Novartis Pharma AG
Active Indication
Tinea corporis [+9]
Inactive Indication
Erythema
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
United Kingdom
First Approval Date03 Oct 1990
100 Clinical Results associated with Shandong Anhong Pharmaceutical Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Shandong Anhong Pharmaceutical Co., Ltd.
Login to view more data
100 Deals associated with Shandong Anhong Pharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Shandong Anhong Pharmaceutical Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 05 Apr 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Terbinafine Hydrochloride
 ( SQLE )		Dermatomycoses
More
Approved
QLNC-3A6 Di-Maleate
 ( FLT3 x PDGFRβ x VEGFR x c-Kit )		Neoplasms
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free